DK
Dilip Kadambi
About Dilip Kadambi
Data last updated:
Dilip Kadambi is a Director at Fortis Healthcare Limited (since 2020), Director at Agilus Diagnostics Limited (since 2021) and Nominee Director at Gleneagles Healthcare India Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Healthcare and Financial Services. The 4 current companies with reported revenue have a combined latest revenue of ₹10,641 Cr; the largest is Fortis Healthcare Limited at ₹7,850 Cr (FY 2025). Earlier, Dilip Kadambi was a Managing Director at Rbs Corporate Finance India Private Limited (2008–2012) and Director at Manipal Hospitals Private Limited (2017–2019) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Fortis Healthcare Limited L85110PB1996PLC045933 | Director | 04 Jun 2020 | 1996 | ₹7,850 Cr (FY 2025) | Active |
 Agilus Diagnostics Limited U74899PB1995PLC045956 | Director | 06 Apr 2021 | 1995 | ₹1,432 Cr (FY 2025) | Active |
 Gleneagles Healthcare India Private Limited U85110TN1998PTC093106 | Nominee Director | 05 Sep 2025 | 1998 | ₹1,065 Cr (FY 2025) | Active |
 Centre For Digestive And Kidney Diseases (India) Private Limited U85110MH2004PTC146014 | Additional Director | 10 Sep 2025 | 2004 | ₹294 Cr (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Rbs Corporate Finance India Private Limited U65910MH2000PTC240476 | Managing Director | 15 Apr 2008 | 2000 | ₹3.56 Cr (FY 2017) | Amalgamated |
 Manipal Hospitals Private Limited U85110KA2003PTC033055 | Director | 29 Aug 2017 | 2003 | ₹2,538 Cr (FY 2026) | Active |
| Navketan Nursing Home Pvt Ltd U85110KA1991PTC123438 | Director | 29 Aug 2017 | 1991 | ₹90.23 Cr (FY 2019) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Dilip Kadambi
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dilip Kadambi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dilip Kadambi
Dilip Kadambi currently holds 4 directorships: Fortis Healthcare Limited (Director, since 04 Jun 2020, revenue ₹7,850 Cr (FY 2025)); Agilus Diagnostics Limited (Director, since 06 Apr 2021, revenue ₹1,432 Cr (FY 2025)); Gleneagles Healthcare India Private Limited (Nominee Director, since 05 Sep 2025, revenue ₹1,065 Cr (FY 2025)); Centre For Digestive And Kidney Diseases (India) Private Limited (Additional Director, since 10 Sep 2025, revenue ₹294 Cr (FY 2023)).
Dilip Kadambi was first appointed on 15 Apr 2008 as Managing Director at Rbs Corporate Finance India Private Limited. The most recent appointment on record is 10 Sep 2025 at Centre For Digestive And Kidney Diseases (India) Private Limited.
The 4 current companies of Dilip Kadambi that report revenue have a combined latest revenue of ₹10,641 Cr: Fortis Healthcare Limited ₹7,850 Cr (FY 2025); Agilus Diagnostics Limited ₹1,432 Cr (FY 2025); Gleneagles Healthcare India Private Limited ₹1,065 Cr (FY 2025); Centre For Digestive And Kidney Diseases (India) Private Limited ₹294 Cr (FY 2023).
Dilip Kadambi held 3 earlier board appointments: Rbs Corporate Finance India Private Limited (Managing Director, 15 Apr 2008 to 15 Feb 2012); Manipal Hospitals Private Limited (Director, 29 Aug 2017 to 10 Dec 2019); Navketan Nursing Home Pvt Ltd (Director, from 29 Aug 2017).
The current boards of Dilip Kadambi's companies include Ashok Pandit (Fortis Healthcare Limited), Ashutosh Raghuvanshi (Fortis Healthcare Limited), Ashutosh Raghuvanshi (Fortis Healthcare Limited), Hsiu Chin Keith Lim (Fortis Healthcare Limited), Indrajit Banerjee (Fortis Healthcare Limited), Leo Puri (Fortis Healthcare Limited), among others.